The Emerging Risk of Peptides in Supplements LegitScript GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche BPC 157 Peptide Therapy Doctors Supplement Store Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law